A possible interpretation of these findings could be that after absorption through the animal peritoneal vascular system, an effective dose of 213Bi-PAI2 can prevent the dissemination of the cancer and completely target and kill metastatic cancer cells or micrometastases that express uPA, leading to their complete regression. The gene discussed is SERPINB2; the disease is cancer.